Estrella Immunopharma, Inc. (ESLA) vs MARKER THERAPEUTICS, INC. (MRKR)

Estrella Immunopharma, Inc. and MARKER THERAPEUTICS, INC. are both Biotechnology companies. Estrella Immunopharma, Inc. and MARKER THERAPEUTICS, INC. are of similar size ($20.5M and $19.8M). Across the 9 metrics below, Estrella Immunopharma, Inc. leads on 5 and MARKER THERAPEUTICS, INC. on 4.

Valuation

Metric ESLA MRKR Biotechnology median
P/E n/m n/m 7.88
P/S n/m 4.67 11.47
P/B n/m 1.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 2.33 10.73
Earnings yield (50.81%) (35.65%) (28.84%)
Free cash flow yield (45.47%) (98.59%) (23.03%)

Profitability

Metric ESLA MRKR Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 148.05% (76.87%) (57.72%)
Return on assets (416.74%) (59.33%) (49.22%)
Return on invested capital 0.00% (566.75%) 0.00%

Growth

Metric ESLA MRKR Biotechnology median
Revenue growth (TTM) — (27.83%) 5.64%
EPS growth (last fiscal year) (188.78%) 33.61% —
Revenue growth, 5-year CAGR — 50.02% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ESLA MRKR Biotechnology median
Debt to equity 0.00 0.07 0.00
Current ratio 0.20 6.03 4.73
Net debt to EBITDA 0.11 1.32 0.96

Dividend

Metric ESLA MRKR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ESLA MRKR Biotechnology median
Market cap 20.49m 19.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack